AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013
Nov 5, 2013
30583_dirs_2013-11-05_decd91f5-b3b4-4ded-a910-298c05ed83ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-11-01
Reporting Person: Ajer Jeffrey Robert (SVP, Chief Commercial Of)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-10-31 | Common Stock | A | 99 | $27.9055 | Acquired | 14979 | Direct |
| 2013-11-01 | Common Stock | S | 99 | $63.16 | Disposed | 14880 | Direct |
Footnotes
F1: The reporting person is reporting the acquisition of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of May 1, 2013 to October 31, 2013.
F2: Transaction made pursuant to a Rule 10b5-1 plan executed on December 11, 2012.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19